Streetbeat News

Equity Actions

SKIN

Analyst ratings for Beauty Health (NASDAQ:SKIN) have been updated, with 5 analysts providing evaluations in the last three months. The average 12-month price target for SKIN has been raised to $3.6, a 38.46% increase from the previous target of $2.60. Analysts' sentiments have shifted slightly towards a more neutral stance, with recent ratings indicating 4 indifferent and 1 somewhat bearish outlooks. Beauty Health's financial performance shows a decline in revenue growth and challenges in ROE, but a strong net margin and ROA. The company's debt-to-equity ratio is higher than the industry average, indicating a reliance on borrowed funds.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 6:00 pm

GLST

Global Star Acquisition and its units, along with K Enter, have amended their merger agreement, reducing the base value of the merger consideration for company shareholders from $610 million to $590 million.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 5:49 pm

AMZN

BABA

NKE

TSLA

UAA

Today's session highlighted significant whale activity in the options market for 10 consumer discretionary stocks, indicating potential trading opportunities. The activity involved both bullish and bearish sentiments across various stocks, including notable companies like Tesla, Amazon, and Nike. The transactions, which ranged from put and call options, sweeps to trades, suggest diverse market expectations and strategies among large investors.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 5:35 pm

BAC

COF

MMC

MTB

RILY

STNE

Today's session highlighted significant options activity in the Financials sector, with notable trades in stocks like RILY, COF, STNE, SQ, BAC, MS, MTB, GS, C, and MMC. The activity ranged from bullish to bearish sentiments, with various expiration dates and strike prices. This options activity could indicate potential trading opportunities based on the whales' movements.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 5:35 pm

AMD

NVDA

PLTR

Today's session highlighted significant options activity for 10 Information Technology stocks, indicating potential trading opportunities based on whale alerts. These alerts track large transactions and divergences in market estimations of option values. Notable activities include bullish put sweeps for AMD, DOMO, and TSM, bearish call sweeps for NVDA and PLTR, among others, with various expiration dates and strike prices.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 5:35 pm

EWJ

EWJV

HEWJ

Goldman Sachs highlights 'Seven Samurai' stocks as leading Japanese equities, showcasing their performance and potential compared to the U.S.'s 'Magnificent Seven'. These stocks, including Tokyo Electron, Mitsubishi Corporation, Toyota, Nintendo, Fast Retailing, Sony, and Mitsubishi UFJ Financial Group, offer diversified investment opportunities with lower valuations and higher yields. Warren Buffett has invested in one of these, Mitsubishi Corp, through Berkshire Hathaway. Additionally, ETFs like iShares MSCI Japan ETF, iShares Currency Hedged MSCI Japan, and iShares MSCI Japan Value ETF provide exposure to these equities.

Portfolio Pulse from Stjepan Kalinic

March 14, 2024 | 5:28 pm

MTCH

Match Group, known by its ticker symbol MTCH, has attracted a second activist investor, Anson Funds, according to Bloomberg. This development could indicate potential changes in the company's strategy or management to address the concerns of these investors.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 5:03 pm

MTCH

Match Group, known by its ticker symbol MTCH, has attracted a second activist investor, Anson Funds, according to Bloomberg. This development could signal potential changes in the company's strategy or management, as activist investors typically seek to influence a company's operations, financial strategies, or corporate governance to unlock shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 5:02 pm

ORCL

19 analysts have recently shared their evaluations of Oracle (NYSE:ORCL), showing a mix of bullish and bearish perspectives. The average 12-month price target for Oracle has risen by 8.9% to $136.0, with a high estimate of $160.00 and a low estimate of $105.00. Analysts have adjusted their ratings and price targets, reflecting a positive shift in sentiment towards Oracle. The company's financials indicate strong performance with a notable revenue growth rate, exceptional net margin, and impressive ROE and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 5:00 pm

MCHP

Microchip Technology (NASDAQ:MCHP) has seen varied analyst ratings over the past three months, with a recent shift towards a more cautious outlook. The average 12-month price target has been adjusted to $91.75, down from $95.25, reflecting a 3.67% decrease. Analyst actions include maintaining, raising, and lowering ratings and price targets, indicating a nuanced view of the company's future performance. Despite a -18.6% decline in revenue growth for the last quarter of 2023 and challenges in market capitalization and asset utilization, Microchip Technology maintains a strong net margin of 23.74% and an impressive ROE of 5.97%, though it carries a higher debt-to-equity ratio of 0.81.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 5:00 pm